1.
Offidani M, Corvatta L, Marconi M, Visani G, Alesiani F, Brunori M, Galieni P, Catarini M, Burattini M, Centurioni R, Rupoli S, Scortechini A, Giuliodori L, Candela M, Capelli D, Montanari M, Olivieri A, Piersantelli M, Leoni P. Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study. Haematologica [Internet]. 2006Jan.1 [cited 2026Nov.16];91(1):133-6. Available from: https://haematologica.org/article/view/3811